Goodwin

Partner

Morag Peberdy has specialized in life sciences work for more than twenty years. She advises biotech and pharmaceutical companies, ranging from start-ups through to big pharma, on drafting and negotiating intellectual property-related agreements. She has particular expertise in foundational IP licenses and strategic drug discovery collaborations.

In her work with innovative multi-national, national, and start-up life sciences companies, Morag regularly:

Provides strategic advice on licensing and partnering Assists clients to put in place R&D and collaboration agreements, patent licenses, intellectual property pipeline arrangements, joint ventures, option agreements, strategic alliances, and other commercial and IP-related contracts; and Advises on intellectual property issues arising in corporate transactions, including mergers and acquisitions, initial public offerings, venture capital investments, royalty monetizations and restructurings

Morag had a background in biological sciences prior to qualifying as a lawyer and sits on the PLC Life Sciences Consultation Board and the Intellectual Property Advisory Committee of the Bio Industry Association, advising across the spectrum of intellectual property issues impacting life science companies.

Morag’s insight into both contentious and non-contentious IP matters enables her to bring a valuable perspective and breadth of knowledge to strategic intellectual property issues, which is invaluable in assisting clients’ business objectives.

Diploma, Intellectual Property Law and Practice, University of Bristol, Bristol, UK; Diploma, Legal Practice, Nottingham Law School (Distinction); Post-Graduate Diploma in Law, Nottingham Law School (Distinction); MA, Biological Sciences, University of Oxford (First Class Honors)